Clinical Trial Update: Rifampicin Explorative PK Study for Tuberculous Meningitis Comparing Oral and Intravenous Preparation [Phase 2]

View source ↗

Summary

A phase 2 explorative pharmacokinetic study comparing oral and intravenous rifampicin for tuberculous meningitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculous Meningitis

Drugs mentioned

• Rifampicin

Snippet

Sponsor: Universitas Padjadjaran | Conditions: Tuberculous Meningitis | Phase 2 | Status: COMPLETED